EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prognostic factors after multimodality treatment for pleural mesothelioma

Masaki Hashimoto, Shota Nakamura, Akifumi Nakamura, Toru Nakamichi, Ayumi Kuroda, Kyoshiro Takegahara, Taketo Kato, Koichi Fukumoto, Seiji Matsumoto, Nobuyuki Kondo, Toyofumi Fengshi Chen-Yoshikawa, Seiki Hasegawa und 1 weitere

Interdisciplinary CardioVascular and Thoracic Surgery · 02.11.2026

DOI: 10.1093/icvts/ivag296 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Interdisciplinary CardioVascular and Thoracic Surgery, online erschienen am 02.11.2026. Verfasst von Masaki Hashimoto und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Hyogo Medical University, Nishinomiya, Japan. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To investigate prognostic factors associated with overall survival (OS) in patients with pleural mesothelioma (PM) undergoing curative-intent surgery as part of multimodality treatment (MMT).

Methods

This retrospective two-centre cohort included 255 patients treated between 2006 and 2019. OS was measured from the date of histological diagnosis and analyzed using Cox proportional hazards regression as the primary analysis. A secondary logistic regression analysis evaluated 5-year survival among patients with ascertainable 5-year vital status. A sensitivity Cox analysis used the date of surgery as the time origin.

Results

Among 255 patients, 77 (30.2%) survived ≥5 years after diagnosis. All 255 patients and 192 deaths were included in the primary Cox analysis. Age ≥70 years (HR 1.49, 95% CI 1.04–2.14; P=.029), non-epithelioid histology (HR 2.22, 95% CI 1.33–3.72; P=.002), preoperative T2–4 disease according to the 9th edition TNM classification (HR 2.47, 95% CI 1.78–3.43; P<.001), severe postoperative complications (HR 2.62, 95% CI 1.85–3.70; P<.001), and blood loss >1465 mL (HR 1.39, 95% CI 1.03–1.87; P=.030) were independently associated with poorer OS. Fifteen patients alive at last contact but censored before 5 years were excluded from the secondary 5-year analysis, leaving 240 patients (77 surviving ≥5 years and 163 dying before 5 years). Results were materially unchanged when OS was measured from surgery.

Conclusions

Advanced age, non-epithelioid histology, higher preoperative T category according to the 9th edition TNM classification, severe postoperative complications, and greater intraoperative blood loss were independently associated with poorer OS in this highly selected surgically treated cohort.

Schlagwörter

Stichwörter der Autor:innen

Pleural mesotheliomalong-term survivalsurgery

Autor:innen und Institutionen

  • Department of Thoracic Surgery, Hyogo Medical University, Nishinomiya, Japan.
  • Department of Thoracic Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Department of Thoracic Oncology, Hyogo Medical University, Nishinomiya, Japan.

Zitieren

APA

Hashimoto, M., Nakamura, S., Nakamura, A., Nakamichi, T., Kuroda, A., Takegahara, K., Kato, T., Fukumoto, K., Matsumoto, S., Kondo, N., Chen-Yoshikawa, T. F., Hasegawa, S., & Funaki, S. (2026). Prognostic factors after multimodality treatment for pleural mesothelioma. Interdisciplinary CardioVascular and Thoracic Surgery. https://doi.org/10.1093/icvts/ivag296

Vancouver

Hashimoto M, Nakamura S, Nakamura A, Nakamichi T, Kuroda A, Takegahara K, et al. Prognostic factors after multimodality treatment for pleural mesothelioma. Interdisciplinary CardioVascular and Thoracic Surgery. 2026. doi:10.1093/icvts/ivag296

BibTeX
@article{Hashimoto2026,
  author = {Hashimoto, Masaki and Nakamura, Shota and Nakamura, Akifumi and Nakamichi, Toru and Kuroda, Ayumi and Takegahara, Kyoshiro and Kato, Taketo and Fukumoto, Koichi and Matsumoto, Seiji and Kondo, Nobuyuki and Chen-Yoshikawa, Toyofumi Fengshi and Hasegawa, Seiki and Funaki, Soichiro},
  title = {Prognostic factors after multimodality treatment for pleural mesothelioma},
  journal = {Interdisciplinary CardioVascular and Thoracic Surgery},
  year = {2026},
  doi = {10.1093/icvts/ivag296}
}
Kostenlos starten →